π΅οΈ Precigen, Inc. ($PGEN)
SEC insider & ownership activity, last 12 months Β· CIK 1356090 Β· every row links its SEC filing
Over the last 12 months insiders sold $66.8M against $236K of open-market buying. Randal J. Kirk sold $60.8M through a program of 7 sale notices averaging $8.6M (SepβMar). 1 planned sale is pending, the largest $165K (Thomasian Harry Jr.). No red-flag 8-Ks in the window.
π¨ 2 signals active β
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $236K (7 lots) Β· 7 sellers, $66.8M (40 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Randal J. Kirk | 0 | β | 28 | $60.8M | Mar 30, 2026 |
| Sabzevari Helen | 0 | β | 2 | $2.6M | Jun 29, 2026 |
| Jeffrey B. Kindler | 0 | β | 3 | $1.5M | Dec 12, 2025 |
| Thomasian Harry Jr. | 2 | $40K | 3 | $1.3M | Jul 1, 2026 |
| Rutul R. Shah | 1 | $7K | 2 | $437K | Jun 29, 2026 |
| Nancy H. Agee | 3 | $168K | 0 | β | Sep 4, 2025 |
| Tennant Phil | 1 | $21K | 1 | $132K | May 28, 2026 |
| Donald P. Lehr | 0 | β | 1 | $127K | May 28, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Randal J. Kirk | 39.8% | 13D | Dec 30, 2024 | filing β | |
| Randal J. Kirk | 35.9% | 13D | Mar 30, 2026 | filing β | |
| R.J. KIRK Declaration of Trust | 26.1% | 13D | Mar 30, 2026 | filing β | |
| R.J. KIRK Declaration of Trust | 22.0% | 13D | Dec 30, 2024 | filing β | |
| Third Security, LLC | 11.1% | 13D | Dec 30, 2024 | filing β | |
| Patient Capital Management, LLC | 10.2% | 13G | Feb 13, 2026 | filing β | |
| William H. Miller III Living Trust Dated April 17, 2017 | 9.2% | 13G | Sep 23, 2025 | filing β | |
| Patient Opportunity Trust, A Series of Advisor Managed Portfolios | 7.8% | 13G | Feb 13, 2026 | filing β | |
| Patient Capital Management, LLC | 6.5% | 13G | Feb 12, 2025 | filing β | |
| Third Security, LLC | 5.9% | 13D | Mar 30, 2026 | filing β | |
| Sunset 2020 LLC | 5.6% | 13D | Dec 30, 2024 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Thomasian Harry Jr. | $949K | Jul 1, 2026 | filing β |
| Sabzevari Helen | $2.0M | Jun 29, 2026 | filing β |
| Rutul R. Shah | $251K | Jun 29, 2026 | filing β |
| Thomasian Harry Jr. | $165K | Jun 29, 2026 | filing β |
| Randal J. Kirk | $17.5M | Mar 30, 2026 | filing β |
| Randal J. Kirk | $8.2M | Dec 22, 2025 | filing β |
| Jeffrey Kindler | $869K | Dec 12, 2025 | filing β |
| Randal J. Kirk | $3.8M | Nov 20, 2025 | filing β |
| Randal J. Kirk | $4.6M | Nov 19, 2025 | filing β |
| Jeffrey Kindler | $351K | Sep 30, 2025 | filing β |
| Randal J. Kirk | $6.6M | Sep 30, 2025 | filing β |
| Jeffrey Kindler | $245K | Sep 29, 2025 | filing β |
| Randal J. Kirk | $970 | Sep 19, 2025 | filing β |
| Randal J. Kirk | $19.6M | Sep 18, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 18, 2026 | filing β |
| Shareholder vote (5.07) | Jun 18, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing β |
| Earnings (2.02) | May 13, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing β |
| Earnings (2.02) | Mar 25, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing β |
| Earnings (2.02) | Nov 13, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing β |
| Unregistered equity sale (3.02) | Sep 15, 2025 | filing β |
| Material agreement (1.01) | Sep 3, 2025 | filing β |
| New financial obligation (2.03) | Sep 3, 2025 | filing β |
| Reg FD disclosure (7.01) | Sep 3, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Sep 3, 2025 | filing β |
| Reg FD disclosure (7.01) | Aug 18, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 18, 2025 | filing β |
| Material agreement (1.01) | Aug 13, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 13, 2025 | filing β |